Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the page. The change represents a revision of the page version rather than modifications to the study data.SummaryDifference0.1%

- Check19 days agoChange DetectedA new publication citation by Fountzilas et al. is added to the study's publications with full bibliographic details, replacing the previous online-ahead-of-print entry.SummaryDifference0.1%

- Check26 days agoChange DetectedNo additions or deletions are present. The content appears unchanged relative to the captured data.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page’s version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a new site release. No changes to the underlying study content are reflected.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows revision v3.5.2 and no longer lists v3.5.0.SummaryDifference0.1%

- Check47 days agoChange DetectedPublications section updated: added the 2026 Int J Cancer paper on TP53 mutation and removed the earlier Int J Cancer entry.SummaryDifference0.1%

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.